Differential sensitivity of mouse oocytes to colchicine-induced aneuploidy.
Unpublished results from our laboratory showed that colchicine increased the incidence of hyperploid mouse metaphase II (MII) oocytes when injected at the same time as human chorionic gonadotrophin (HCG). The objective of the present study was to determine whether the time of administering colchicine influenced the incidence of aneuploidy in MII oocytes. CD-1 mice were given pregnant mare's serum (PMS) and 48 hr later, HCG. An intraperitoneal injection of 0.2 mg/kg colchicine was given at +4, +2, 0, -2, or -4 hr relative to HCG. Oocytes were collected 17 hr post-HCG and processed, and chromosomes were subsequently C-banded. The percentage of hyperploid oocytes was 0.77, 2.56, 5.71, 7.79, 3.54, and 2.70 for control, +4, +2, 0, -2, or -4 hr pre/post-HCG, respectively. Chi-square analyses of these data demonstrated that colchicine significantly increases the proportion of aneuploid oocytes, and that the relative sensitivity of colchicine-induced aneuploidy depends upon the time that this drug is administered relative to HCG.
Department of Obstetrics and Gynecology, Louisiana State University Medical Center, Shreveport 71130.
J B
JB
Mailhes
Z P
ZP
Yuan
D000782:Aneuploidy; D000818:Animals; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology*; D005260:Female; D051379:Mice; D009865:Oocytes / Q000187:drug effects*; D010062:Ovulation Induction; D013997:Time Factors
D006063:Chorionic Gonadotropin; D003078:Colchicine